These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 636802)

  • 1. Comparative evaluation of neuro-muscular blockade after pancuronium administration in patients with and without renal failure.
    D'Hollander AA; Camu F; Sanders M
    Acta Anaesthesiol Scand; 1978; 22(1):21-6. PubMed ID: 636802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.
    Nathan N; Bonada G; Feiss P
    Acta Anaesthesiol Belg; 1996; 47(4):187-93. PubMed ID: 9093646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG; Lewis B; Bedocs NM
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide.
    Somogyi AA; Shanks CA; Triggs EJ
    Eur J Clin Pharmacol; 1977 Aug; 12(1):23-9. PubMed ID: 332502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged neuromuscular blockade with pancuronium in the presence of acute renal failure: a case report.
    Geha DG; Blitt CD; Moon BJ
    Anesth Analg; 1976; 55(3):343-5. PubMed ID: 945014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atracurium and pancuronium in renal insufficiency.
    Berntman L; Rosberg B; Shweikh I; Yousef H
    Acta Anaesthesiol Scand; 1989 Jan; 33(1):48-52. PubMed ID: 2644748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.
    Rørvik K; Husby P; Gramstad L; Vamnes JS; Bitsch-Larsen L; Koller ME
    Br J Anaesth; 1988 Aug; 61(2):180-5. PubMed ID: 2901270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine.
    Gramstad L
    Br J Anaesth; 1987 Aug; 59(8):995-1003. PubMed ID: 2888477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of pancuronium in renal failure: no recurarization.
    Bevan DR; Archer D; Donati F; Ferguson A; Higgs BD
    Br J Anaesth; 1982 Jan; 54(1):63-8. PubMed ID: 6275872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
    Rupp SM; McChristian JW; Miller RD; Taboada JA; Cronnelly R
    Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of cimetidine on neuromuscular blockade by succinylcholine and pancuronium].
    Sato Y; Tsuchida H; Harada Y; Namiki A
    Masui; 1990 Feb; 39(2):168-73. PubMed ID: 2325250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacodynamic model for pancuronium.
    Hull CJ; Van Beem HB; McLeod K; Sibbald A; Watson MJ
    Br J Anaesth; 1978 Nov; 50(11):1113-23. PubMed ID: 718781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of pancuronium and neuromuscular blockade after injection into the isolated arm, bolus injection, and continuous infusion.
    Agoston S; Feldman SA; Miller RD
    Anesthesiology; 1979 Aug; 51(2):119-22. PubMed ID: 453611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the degree of muscle blockade: a comparative study using electromyography of the muscular relaxation induced by pancuronium, atracurium and vecuronium].
    Cabarrocas E; Roigé J; Durán L; Gancedo V; Ballvé M; Martínez Bayón MJ
    Rev Esp Anestesiol Reanim; 1990; 37(3):137-41. PubMed ID: 1975113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of the pharmacodynamic interaction between pancuronium and mivacurium.
    Beaussier M; Deriaz H; De Traverse A; Abdelhalim Z; Lienhart A
    Br J Anaesth; 1998 Aug; 81(2):251-2. PubMed ID: 9813534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Train-of-four recovery after pharmacologic antagonism of pancuronium-, pipecuronium-, and doxacurium-induced neuromuscular block in anaesthetized humans.
    Stinson LW; Lanier WL; Lennon RL
    Acta Anaesthesiol Scand; 1995 Apr; 39(3):406-10. PubMed ID: 7793225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with pancuronium before suxamethonium administration in patients heterozygous for the usual and the atypical plasma cholinesterase gene.
    Ostergaard D; Viby-Mogensen J; Hanel HK; Skovgaard LT
    Acta Anaesthesiol Scand; 1991 Aug; 35(6):502-7. PubMed ID: 1897345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of train-of-four ratio to twitch depression during pancuronium-induced neuromuscular blockade.
    Graham GG; Morris R; Pybus DA; Torda TA; Woodey R
    Anesthesiology; 1986 Dec; 65(6):579-83. PubMed ID: 3789430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of neuromuscular blockade and reversibility of AH 8165 and pancuronium bromide in man.
    Camu F; Sanders M; D'Hollander A
    Acta Anaesthesiol Belg; 1976; 27 suppl():80-5. PubMed ID: 13601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of pancuronium during predetermined intensities of neuromuscular blockade.
    Shanks CA; Somogyi AA; Triggs EJ
    Br J Anaesth; 1978 Mar; 50(3):235-9. PubMed ID: 637996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.